SCHEMBL3968171

SCHEMBL3968171

[C]#Cc1ccc(OC(C)=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.57
MAPT P10636 3/20 0.52
POLB P06746 1/20 0.52
PKM P14618 1/20 0.52
ELANE P08246 3/20 0.50
HSD17B10 Q99714 1/20 0.48
GAA P10253 2/20 0.47
ALDH1A1 P00352 1/20 0.47
HSP90AA1 P07900 1/20 0.47
CYP3A4 P08684 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 2/20 0.46
TTR P02766 1/20 0.46
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GLA P06280 1/20 0.44
ESR1 P03372 1/20 0.43
PGR P06401 1/20 0.43
CHRM2 P08172 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16327448 0.83 LMNA (0.61) LMNAMAPTPOLBPKMELANE
SCHEMBL269329 0.82 LMNA (0.80) LMNAMAPTPOLBPKMELANE
SCHEMBL489581 0.81 LMNA (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL14760365 0.79 LMNA (0.76) LMNAMAPTPOLBPKMELANE
Lithium SCHEMBL30522746 0.79 LMNA (0.76) LMNAMAPTPOLBPKMELANE
SCHEMBL597490 0.79 LMNA (0.57) LMNAMAPTPOLBPKMELANE
SCHEMBL337646 0.79 LMNA (0.57) LMNAMAPTPOLBPKMELANE
SCHEMBL20212072 0.78 LMNA (0.55) LMNAMAPTPOLBPKMELANE
SCHEMBL7523552 0.76 ELANE (0.61) LMNAMAPTPOLBPKMELANE
SCHEMBL10778741 0.76 HSD17B10 (0.59) LMNAMAPTPOLBPKMELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1902049-A2 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS Bayer Schering Pharma Aktiengesellschaft (DE) 2008-03-26 EP claimed
US-20070010514-A1 Non-steroidal progesterone receptor modulators BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-01-11 US claimed
WO-2006136461-A2 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-12-28 WO claimed
US-7507784-B2 Liquid crystalline thermosets from ester, ester-imide, and ester-amide oligomers THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) 2009-03-24 US disclosed
US-7497970-B2 Chiral agent for liquid crystal, liquid crystal composition and polymer, as well as filter for optical recording medium, optical recording medium and color filter liquid for crystal FUJIFILM CORPORATION (JP) 2009-03-03 US disclosed
EP-1320567-B1 LIQUID CRYSTALLINE THERMOSETS FROM ESTER, ESTER-IMIDE, AND ESTER-AMIDE OLIGOMERS NASA (US) 2008-12-17 EP disclosed
US-20070228325-A1 Chiral agent for liquid crystal, liquid crystal composition and polymer, as well as filter for optical recording medium, optical recording medium and color filter liquid for crystal FUJIFILM CORPORATION (JP) 2007-10-04 US disclosed
US-20050209429-A1 Liquid crystalline thermosets from ester, ester-imide, and ester-amide oligomers USA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) 2005-09-22 US disclosed
US-6939940-B2 Liquid crystalline thermosets from ester, ester-imide, and ester-amide oligomers THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) 2005-09-06 US disclosed
US-6610216-B2 Multicolor photopolymerizable compound FUJI PHOTO FILM CO., LTD. (JP) 2003-08-26 US disclosed
EP-1320567-A1 LIQUID CRYSTALLINE THERMOSETS FROM ESTER, ESTER-IMIDE, AND ESTER-AMIDE OLIGOMERS The Government of the United States of America as represented by the Administrator of the National Aeronautics and Space Adm. (US) 2003-06-25 EP disclosed
US-20030006398-A1 Optically active compound, photoreactive chiral agent, liquid crystal composition, method for changing helical structure of liquid crystal, method for fixing helical structure of liquid crystal, liquid crystal color filter, optical film, and recording medium FUJI PHOTO FILM CO., LTD. 2003-01-09 US disclosed
US-20020132933-A1 Liquid crystalline thermosets from ester, ester-imide, and ester-amide oligomers UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION 2002-09-19 US disclosed
WO-2002022706-A1 LIQUID CRYSTALLINE THERMOSETS FROM ESTER, ESTER-IMIDE, AND ESTER-AMIDE OLIGOMERS THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (NASA) (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010514-A1 Non-steroidal progesterone receptor modulators PGR, PGRMC1, CYP19A1 LMNA 1568/4885MAPT 4874/4885POLB 3187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.